ask="12.2500"
ask_size="100"
average_daily_volume="369"
bid="2.1500"
bid_size="100"
book_value="3.9850"
change="+0.3533"
change_from_200_day_moving_average="0.2548"
change_from_50_day_moving_average="0.4762"
change_from_52_week_high="-4.2967"
change_From_52_week_low="2.7833"
change_in_percent="+5.3208%"
close="6.9933"
dividend_pay_date="2/1/2017"
dividend_per_share="0.6000"
dividend_yield="8.7600"
earnings_per_share="-4.0560"
ebitda="-14.68M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="1/13/2017"
float_shares="3373000"
high="6.9999"
high_52_weeks="11.2900"
last_trade_date="2/15/2017"
last_trade_price="6.9933"
last_trade_size="400"
last_trade_time="1:48pm"
low="6.9634"
low_52_weeks="4.2100"
market_capitalization="29.73M"
moving_average_200_day="6.7385"
moving_average_50_day="6.5171"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="N/A"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+3.7806%"
percent_change_from_50_day_moving_average="+7.3076%"
percent_change_from_52_week_high="-38.0576%"
percent_change_from_52_week_low="+66.1116%"
previous_close="6.6400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.6662"
price_per_sales="28.5984"
revenue="986999.00"
shares_outstanding="4251000"
short_ratio="0.4300"
stock_exchange="NCM"
symbol="CYCCP"
volume="1000"
weeks_range_52="4.2100 - 11.2900"
